New guidelines for the management of chronic HBV infection were recently developed by a panel of U.S. hepatologists. This treatment algorithm reflects new developments in the understanding of the advantages and disadvantages of currently approved drug therapies. The guidelines were published in the February 2004 issue of Clinical Gastroenterology and Hepatology.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.